User login
Recent News
MS Physician News - Show All
Drug Addition Found to Reduce Multiple Sclerosis Activity
The addition of daclizumab to interferon beta treatment reduces brain lesion formation in patients with relapsing multiple sclerosis, possibly by increasing the number of a subset of natural killer cells, according to a study published online Feb. 16 in The Lancet Neurology.
Read MoreNeutralizing Antibodies to Interferon Beta May Persist
After cessation of interferon beta therapy for relapsing-remitting multiple sclerosis, neutralizing antibodies to interferon beta can persist, and their presence is associated with poorer clinical outcomes, according to a study published online Feb. 8 in the Archives of Neurology.
Read MoreMagnetic Resonance Imaging Examined in Multiple Sclerosis
The use of functional MRI to assess patterns of brain activation in adults and children with multiple sclerosis may offer insight into disease progression among these groups, according to research published in the February issue of Radiology.
Read MoreGeneral Neurology Physician News - Show All
Whole-Genome Sequencing May Identify Causes of Disease
Whole-genome sequencing has the potential to identify clinically relevant variants and provide important diagnostic information, according to a study published online March 10 in the New England Journal of Medicine.
Read MoreLacosamide Shows Benefit in Partial-Onset Seizures
The use of lacosamide as an adjunctive treatment in patients with uncontrolled partial-onset seizures is effective in reducing seizure frequency and may provide additional benefits for some patients with secondarily generalized tonic-clonic seizures, according to research published online Jan. 27 in Epilepsia.
Read MoreMS News for Your Patient - Show All
Reading Remediation Seems to Rewire the Brain
Study findings could have implications for autism, stroke and other conditions.
Read MoreFitness Boosts Brain Power in Multiple Sclerosis Patients
MRI scans show less structural damage in those who exercise.
Read MoreMigraine Tied to Raised Multiple Sclerosis Risk
But overall odds are still low and headache sufferers shouldn't worry, researcher says.
Read More |  |  | |